Patents by Inventor David Fitzpatrick

David Fitzpatrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11858999
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or more IL-17 ligands. The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and antibodies that bind thereto. Aspects of the invention also include antibodies that compete for binding with the IL-17RA neutralizing antibodies described herein.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: January 2, 2024
    Assignee: AMGEN K-A, INC.
    Inventors: Joel E. Tocker, Jacques J. Peschon, David Fitzpatrick, James F. Smothers, Christopher Mehlin, Ai Ching Lim
  • Patent number: 11180564
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or more IL-17 ligands. The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and antibodies that bind thereto. Aspects of the invention also include antibodies that compete for binding with the IL-17RA neutralizing antibodies described herein.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: November 23, 2021
    Assignee: AMGEN K-A, INC.
    Inventors: Joel E. Tocker, Jacques J. Peschon, David Fitzpatrick, James F. Smothers, Christopher Mehlin, Ai Ching Lim
  • Publication number: 20200362045
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or more IL-17 ligands. The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and antibodies that bind thereto. Aspects of the invention also include antibodies that compete for binding with the IL-17RA neutralizing antibodies described herein.
    Type: Application
    Filed: August 5, 2020
    Publication date: November 19, 2020
    Inventors: Joel E. Tocker, Jacques J. Peschon, David Fitzpatrick, James F. Smothers, Christopher Mehlin, Ai Ching Lim
  • Publication number: 20200017591
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or more IL-17 ligands. The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and antibodies that bind thereto. Aspects of the invention also include antibodies that compete for binding with the IL-17RA neutralizing antibodies described herein.
    Type: Application
    Filed: December 21, 2018
    Publication date: January 16, 2020
    Inventors: Joel E. Tocker, Jacques J. Peschon, David Fitzpatrick, James F. Smothers, Christopher Mehlin, Ai Ching Lim
  • Publication number: 20190203209
    Abstract: The invention provides methods and compositions for reducing or preventing fibrosis in a subject suffering from a fibrotic disorder by administering a therapeutically effective amount of at least one antagonist to the cytokine thymic stromal lymphopoietin to the subject. In one embodiment, the methods and compositions further comprise administering at least one additional antagonist to an additional profibrotic cytokine, growth factor or chemokine.
    Type: Application
    Filed: March 18, 2019
    Publication date: July 4, 2019
    Inventors: Michael R. Comeau, David Fitzpatrick
  • Patent number: 10208122
    Abstract: Disclosed is an isolated human monoclonal antibody that specifically binds IL-17 Receptor A, or an IL-17 Receptor A binding fragment thereof, and inhibits IL-17A from binding and activating the receptor. The present disclosure also provides compositions and methods for treating diseases mediated by IL-17 Receptor A activation.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: February 19, 2019
    Assignee: AMGEN K-A, INC.
    Inventors: Joel E. Tocker, Jacques J. Peschon, David Fitzpatrick, James F. Smothers, Christopher Mehlin, Ai Ching Lim
  • Patent number: 9894849
    Abstract: Prescribing a drip line for use in a field includes: accessing soil conditions data that includes vertical transect data relating to at least one vertical transect of soil in a field; based on a plant type and a length of time between a first watering and a second watering of a plant via the drip line, determining, a desired plant available water content of a portion of the soil within the at least one vertical transect to be substantially achieved as a result of the first watering; and based on the vertical transect data, the determined desired plant available water content, climate conditions data and geographical conditions data, determining perforation spacing and flow rate for a set of emitters for the drip line such that the desired plant available water is substantially achieved in the portion of the soil.
    Type: Grant
    Filed: January 15, 2015
    Date of Patent: February 20, 2018
    Assignee: Trimble Inc.
    Inventors: Daniel James Rooney, David Fitzpatrick, Robert Wample
  • Patent number: 9780028
    Abstract: A dielectric layer includes a reflow via. The reflow via is formed by reflow of the dielectric layer away from a raised feature. An interconnect is in contact with the raised feature through the reflow via.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: October 3, 2017
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Kevin Dooley, Roger McQuaid, Liam Cheevers, David Fitzpatrick, Lorraine Byrne
  • Patent number: 9609755
    Abstract: Devices with nanosized particles deposited on shaped surface geometries include a substrate with an active material of nanosized particles deposited on a surface of the substrate. The active material has an edge formed at a position determined with a shaped geometry of the surface.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: March 28, 2017
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Richard Coull, Kevin Dooley, David Fitzpatrick
  • Publication number: 20170081668
    Abstract: The invention provides methods and compositions for reducing or preventing fibrosis in a subject suffering from a fibrotic disorder by administering a therapeutically effective amount of at least one antagonist to the cytokine thymic stromal lymphopoietin to the subject. In one embodiment, the methods and compositions further comprise administering at least one additional antagonist to an additional profibrotic cytokine, growth factor or chemokine.
    Type: Application
    Filed: October 5, 2016
    Publication date: March 23, 2017
    Inventors: Michael R. Comeau, David Fitzpatrick
  • Publication number: 20170084533
    Abstract: A dielectric layer includes a reflow via. The reflow via is formed by reflow of the dielectric layer away from a raised feature. An interconnect is in contact with the raised feature through the reflow via.
    Type: Application
    Filed: November 29, 2016
    Publication date: March 23, 2017
    Inventors: Kevin Dooley, Roger McQuaid, Liam Cheevers, David Fitzpatrick, Lorraine Byrne
  • Patent number: 9583432
    Abstract: A dielectric layer includes a reflow via. The reflow via is formed by reflow of the dielectric layer. An interconnect is in contact through the reflow via.
    Type: Grant
    Filed: January 29, 2013
    Date of Patent: February 28, 2017
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Kevin Dooley, Roger McQuaid, Liam Cheevers, David Fitzpatrick, Lorraine Byrne
  • Publication number: 20160251443
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or more IL-17 ligands. The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and antibodies that bind thereto. Aspects of the invention also include antibodies that compete for binding with the IL-17RA neutralizing antibodies described herein.
    Type: Application
    Filed: March 2, 2016
    Publication date: September 1, 2016
    Inventors: Joel E. Tocker, Jacques J. Peschon, David Fitzpatrick, James F. Smothers, Christopher Mehlin, Ai Ching Lim
  • Publication number: 20160205877
    Abstract: Prescribing a drip line for use in a field includes: accessing soil conditions data that includes vertical transect data relating to at least one vertical transect of soil in a field; based on a plant type and a length of time between a first watering and a second watering of a plant via the drip line, determining, a desired plant available water content of a portion of the soil within the at least one vertical transect to be substantially achieved as a result of the first watering; and based on the vertical transect data, the determined desired plant available water content, climate conditions data and geographical conditions data, determining perforation spacing and flow rate for a set of emitters for the drip line such that the desired plant available water is substantially achieved in the portion of the soil.
    Type: Application
    Filed: January 15, 2015
    Publication date: July 21, 2016
    Inventors: Daniel James Rooney, David Fitzpatrick, Robert Wample
  • Publication number: 20160104675
    Abstract: A dielectric layer includes a reflow via. The reflow via is formed by reflow of the dielectric layer. An interconnect is in contact through the reflow via.
    Type: Application
    Filed: January 29, 2013
    Publication date: April 14, 2016
    Inventors: Kevin Dooley, Roger McQuaid, Liam Cheevers, David Fitzpatrick, Lorraine Byrne
  • Patent number: 9256117
    Abstract: Panoramic imaging systems including rotatable mirrors are provided. A panoramic imaging system includes a rotatable platform, an imaging device mounted to the rotatable platform, and a mirror rotatably mounted to the rotatable platform. The mirror is positioned in an optical path of the imaging device. The mirror and the imaging device are oriented such that the mirror and imaging device are in the same plane, an optical axis of the imaging device is substantially perpendicular to an axis of rotation of the rotatable platform, and an axis of rotation of the mirror is substantially parallel to the axis of rotation of the rotatable platform when the mirror is in an initial position.
    Type: Grant
    Filed: October 7, 2011
    Date of Patent: February 9, 2016
    Assignee: L-3 Communications Cincinnati Electronics Corporation
    Inventors: David Fitzpatrick, Michael Spicer
  • Patent number: 9131311
    Abstract: A canal phone incorporates a transducer within an isolation sound chamber for reproducing sound from an audio source, and a sound-transmission passageway, or ambient sound port, for allowing ambient sounds to enter the isolation sound chamber. The passageway has inner and outer apertures, one oriented towards the ambient noise environment outside of the listener's ear and the other oriented toward the isolated chamber formed by the space between a loudspeaker diaphragm within the canal phone and the tympanum of the listener's ear. The canal phone has a port blocking switch mechanism that selectively opens or closes the aperture of the passageway that is open to the ambient noise. This switch mechanism may also electrically disconnect the transducer and seal either the outer or the inner end of the passageway in different embodiments of the invention.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: September 8, 2015
    Assignee: Polk Audio, LLC
    Inventors: Stuart W. Lumsden, Ken Chae, Scott Orth, David Fitzpatrick
  • Publication number: 20140356355
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or more IL-17 ligands. The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and antibodies that bind thereto. Aspects of the invention also include antibodies that compete for binding with the IL-17RA neutralizing antibodies described herein.
    Type: Application
    Filed: June 13, 2014
    Publication date: December 4, 2014
    Inventors: Joel E. Tocker, Jacques J. Peschon, David Fitzpatrick, James F. Smothers, Christopher Mehlin, Ai Ching Lim
  • Patent number: 8790648
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or more IL-17 ligands. The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and antibodies that bind thereto. Aspects of the invention also include antibodies that compete for binding with the IL-17RA neutralizing antibodies described herein.
    Type: Grant
    Filed: May 15, 2012
    Date of Patent: July 29, 2014
    Assignee: Amgen Inc.
    Inventors: Joel Tocker, Jacques J. Peschon, David Fitzpatrick, James F. Smothers, Christopher Mehlin, Ai Ching Lim
  • Patent number: 8575025
    Abstract: A method of making templated circuitry employs a template system that includes a template of an insulator material on a carrier having a conductive surface. The template includes multiple levels and multiple regions, wherein a first level exposes the conductive surface of the carrier. A first metal is electrochemically deposited on the conductive surface in first regions of the first level. A circuit material is deposited to cover the first metal. The template is etched until a second level of the template exposes the conductive surface in second regions on opposite sides of the first regions. A second metal is electrochemically deposited on the conductive surface in the second regions. The template of deposited materials is transferred from the carrier to a substrate.
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: November 5, 2013
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: David Fitzpatrick, Kevin Dooley, Lorraine Byrne